2024
The Impact of Obesity on the Prevalence and Complications of Perianal Fistulas of Crohn’s Disease
Youn J, Hsia K, Khadilkar S, Zeina T, Rai P, Rastogi A, Hussani S, Spence S, Adavelly P, Yanes J, Kotlier J, Sweigart B, Levy A, Friedman S. The Impact of Obesity on the Prevalence and Complications of Perianal Fistulas of Crohn’s Disease. Digestive Diseases And Sciences 2024, 1-10. PMID: 39548039, DOI: 10.1007/s10620-024-08729-7.Peer-Reviewed Original ResearchPerianal fistulasPerianal surgeryImpact of obesityComplex fistulasCrohn's perianal fistulasFecal diversionCrohn's diseaseInflammatory bowel diseaseMedian timeBMI categoriesBackgroundThe incidence of obesityHistory of perianal fistulaIncreasing BMI categoryTertiary care centerPerianal fistula surgeryIncidence of obesityRates of obesityCross-sectional studyFistula surgeryAnal surgeryNo significant differenceBackgroundThe incidenceCD patientsFistulaMaximum BMIS1165 Prevalence and Risk Factors for Ulcerative Colitis Flares After Colonoscopy
Khan F, Chung S, Kadhim B, Ameyaw P, Fetene J, Dominguez-Diaz A, Al-Bawardy B, Levy A, Proctor D, Gaidos J. S1165 Prevalence and Risk Factors for Ulcerative Colitis Flares After Colonoscopy. The American Journal Of Gastroenterology 2024, 119: s827-s828. DOI: 10.14309/01.ajg.0001034028.79665.88.Peer-Reviewed Original ResearchTHE IMPACT OF OBESITY ON THE PREVALENCE AND SEVERITY OF PERIANAL COMPLICATIONS OF CROHN'S DISEASE
Youn J, Hsia K, Khadilkar S, Zeina T, Rai P, Rastogi A, Adavelly P, Hussani S, Yanes J, Kotlier J, Spence S, Levy A, Friedman S. THE IMPACT OF OBESITY ON THE PREVALENCE AND SEVERITY OF PERIANAL COMPLICATIONS OF CROHN'S DISEASE. Gastroenterology 2024, 166: s38-s39. DOI: 10.1053/j.gastro.2023.11.112.Peer-Reviewed Original ResearchTHE IMPACT OF OBESITY ON THE PREVALENCE AND SEVERITY OF PERIANAL COMPLICATIONS OF CROHN'S DISEASE
Youn J, Hsia K, Khadilkar S, Zeina T, Rai P, Rastogi A, Adavelly P, Hussani S, Yanes J, Kotlier J, Spence S, Levy A, Friedman S. THE IMPACT OF OBESITY ON THE PREVALENCE AND SEVERITY OF PERIANAL COMPLICATIONS OF CROHN'S DISEASE. Inflammatory Bowel Diseases 2024, 30: s28-s28. DOI: 10.1093/ibd/izae020.064.Peer-Reviewed Original ResearchPrevalence of perianal diseaseSeverity of perianal diseaseBody mass indexInflammatory bowel diseasePerianal surgeryPerianal diseasePerianal fistula surgeryImpact of obesityFecal diversionPerianal fistulasCrohn's diseaseFistula surgeryMedian timeFamily historyHistory of perianal fistulaBody mass index categoriesFamily history of inflammatory bowel diseaseHistory of inflammatory bowel diseaseMaximum body mass indexIncreasing BMI categoryAssociation of obesityNon-obese patientsPerianal fistulizing diseaseCochran-Armitage trend testTertiary care center
2023
S1032 Impact of Obesity and Metabolic Syndrome on Extraintestinal Manifestations of IBD
Hsia K, Youn J, Khadilkar S, Zeina T, Rai P, Rastogi A, Hussani S, Spence S, Adavelly P, Yanes J, Kotlier J, Friedman S, Levy A. S1032 Impact of Obesity and Metabolic Syndrome on Extraintestinal Manifestations of IBD. The American Journal Of Gastroenterology 2023, 118: s784-s784. DOI: 10.14309/01.ajg.0000953768.51593.2b.Peer-Reviewed Original ResearchS867 Consequences of Obesity and IBD: Insights From a Large Outpatient Cohort
Khadilkar S, Hsia K, Youn J, Zeina T, Rai P, Rastogi A, Hussani S, Spence S, Adavelly P, Yanes J, Kotlier J, Friedman S, Levy A. S867 Consequences of Obesity and IBD: Insights From a Large Outpatient Cohort. The American Journal Of Gastroenterology 2023, 118: s643-s643. DOI: 10.14309/01.ajg.0000953108.78585.14.Peer-Reviewed Original ResearchEfficacy and Safety of Hyperbaric Oxygen Therapy in Fistulizing Crohn’s Disease
Dokmak A, Sweigart B, Orekondy N, Jangi S, Weinstock J, Hamdeh S, Kochar G, Shen B, Levy A. Efficacy and Safety of Hyperbaric Oxygen Therapy in Fistulizing Crohn’s Disease. Journal Of Clinical Gastroenterology 2023, 58: 120-130. PMID: 37682003, DOI: 10.1097/mcg.0000000000001905.Peer-Reviewed Original ResearchConceptsHyperbaric oxygen therapySystematic reviewSafety of hyperbaric oxygen therapyHyperbaric oxygen therapy sessionsFistulizing Crohn's diseaseClinical responseCochrane Handbook guidelinesRisk of biasCrohn's diseaseFistulizing CDRandomized controlled trialsWeb of ScienceOxygen therapyStudy biasMeta-analysesCochrane Library databasesMeta-regressionEffective treatment optionBenefits of hyperbaric oxygen therapyControlled trialsRegulate inflammatory pathwaysMeta-analysisInflammatory bowel diseaseIncreased tissue oxygen levelsFistula typeEFFICACY AND SAFETY OF HYPERBARIC OXYGEN THERAPY IN FISTULIZING CROHN’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Dokmak A, Sweigart B, Orekondy N, Jangi S, Hamdeh S, Weinstock J, Kochar G, Shen B, Levy A. EFFICACY AND SAFETY OF HYPERBARIC OXYGEN THERAPY IN FISTULIZING CROHN’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology 2023, 164: s81. DOI: 10.1053/j.gastro.2023.03.152.Peer-Reviewed Original ResearchPredictors and Etiologies of Clinical Relapse Among Patients With Ulcerative Colitis in Deep Remission
Zeina T, Gandhi S, Mittal A, Levy A, Weinstock J, Singh S, Jangi S. Predictors and Etiologies of Clinical Relapse Among Patients With Ulcerative Colitis in Deep Remission. Journal Of Clinical Gastroenterology 2023, 58: 195-199. PMID: 36753459, PMCID: PMC10406966, DOI: 10.1097/mcg.0000000000001834.Peer-Reviewed Original ResearchConceptsEtiology of relapseRisk of relapseCumulative risk of relapseRisk of clinical relapseDeep remissionDiscontinuation of therapyClinical relapseUlcerative colitisNormalization of C-reactive proteinCumulative riskRetrospective cohort studyC-reactive proteinTufts Medical CenterEndoscopic remissionHistological remissionRelapse riskIdentified etiologyRemissionRelapseCohort studyPatientsHistological changesMedical recordsColitisElectronic medical recordsEFFICACY AND SAFETY OF HYPERBARIC OXYGEN THERAPY IN FISTULIZING CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Dokmak A, Sweigart B, Orekondy N, Jangi S, Hamdeh S, Weinstock J, Kochar G, Shen B, Levy A. EFFICACY AND SAFETY OF HYPERBARIC OXYGEN THERAPY IN FISTULIZING CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Inflammatory Bowel Diseases 2023, 29: s63-s63. DOI: 10.1093/ibd/izac247.121.Peer-Reviewed Original ResearchHyperbaric oxygen therapy sessionsHyperbaric oxygen therapyInflammatory bowel diseaseClinical responseClinical remissionRandomized controlled trialsPartial responseRectovaginal fistulaFistulizing CDResponse to HBOTCrohn's diseaseControlled trialsLow adverse event ratesSystematic reviewClinical response rateOutcome dataFistulizing Crohn's diseaseAdjunctive hyperbaric oxygen therapyClosure of fistulaMeta-analysisCochrane Library databasesAdverse event ratesCessation of drainagePotential clinical benefitCase-control study
2022
Adjunctive Hyperbaric Oxygen Therapy for High Risk Peristomal Pyoderma Gangrenosum
Zeina T, Levy A. Adjunctive Hyperbaric Oxygen Therapy for High Risk Peristomal Pyoderma Gangrenosum. Digestive Diseases And Sciences 2022, 67: 4597-4598. PMID: 35989384, DOI: 10.1007/s10620-022-07646-x.Peer-Reviewed Original ResearchSa1561: PREDICTORS OF CLINICAL RELAPSE AMONG PATIENTS WITH ULCERATIVE COLITIS IN ENDO-HISTOLOGIC REMISSION
Zeina T, Gandhi S, Mittal A, Levy A, Weinstock J, Jangi S. Sa1561: PREDICTORS OF CLINICAL RELAPSE AMONG PATIENTS WITH ULCERATIVE COLITIS IN ENDO-HISTOLOGIC REMISSION. Gastroenterology 2022, 162: s-414. DOI: 10.1016/s0016-5085(22)60988-0.Peer-Reviewed Original ResearchNatural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis
Gandhi S, Zelman S, De Armas R, Hemond C, Levy A, Singh S, Korzenik J, Jangi S. Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis. Inflammatory Bowel Diseases 2022, 28: 1614-1617. PMID: 35348692, PMCID: PMC9527605, DOI: 10.1093/ibd/izac053.Peer-Reviewed Original ResearchPREDICTORS OF CLINICAL RELAPSE AMONG PATIENTS WITH ULCERATIVE COLITIS IN ENDO-HISTOLOGIC REMISSION
Zeina T, Gandhi S, Mittal A, Levy A, Weinstock J, Jangi S. PREDICTORS OF CLINICAL RELAPSE AMONG PATIENTS WITH ULCERATIVE COLITIS IN ENDO-HISTOLOGIC REMISSION. Inflammatory Bowel Diseases 2022, 28: s47-s48. DOI: 10.1093/ibd/izac015.073.Peer-Reviewed Original ResearchRisk of relapseCumulative risk of relapseRisk of clinical relapseDeep remissionHistological remissionClinical relapseUlcerative colitisDisease durationEndoscopic remissionCumulative riskMedian follow-up timeDuration of follow-upPredictive of clinical relapseMedian disease durationFollow-up timeRetrospective cohort studyPredictors of relapseMayo endoscopic scoreTufts Medical CenterPatient-reported outcomesMedian ageRelapse rateRelapse riskEndoscopic scoreElectronic medical records
2019
Sa1541 – Metabolomic Analysis of Primary Sclerosing Cholangitis Reveals a Distinct Fingerprint
Levy A, Pratt D, Merker A, Quevedo S, Snapper S, Korzenik J. Sa1541 – Metabolomic Analysis of Primary Sclerosing Cholangitis Reveals a Distinct Fingerprint. Gastroenterology 2019, 156: s-346. DOI: 10.1016/s0016-5085(19)37696-6.Peer-Reviewed Original Research